LAC MED (KLSE:LACMED) unit LAC Medical Supplies secured a letter of award worth 78.9 million ringgit for the supply and delivery of chemical pathology reagents to 10 Health Ministry hospitals in Kedah, Malaysia.

The four-year contract covers an "instrument placement" arrangement for reagents and related testing materials, with deliveries based on actual hospital usage, according to a Tuesday Malaysian bourse filing.

The agreement runs from June 15, 2026, to June 14, 2030, and is expected to contribute positively to company earnings.